Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 3.590
-0.010 (-0.28%)
Sep 29, 2025, 2:45 PM CST
SHA:600664 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 545.17 | 628.85 | 395.26 | 465.15 | 371.08 | -1,078 | Upgrade |
Depreciation & Amortization | 248.46 | 263.76 | 304.2 | 310.39 | 307.54 | 369.75 | Upgrade |
Other Amortization | 35.4 | 29.14 | 21.88 | 10.97 | 19.61 | 12.84 | Upgrade |
Loss (Gain) From Sale of Assets | -4.81 | -1.03 | -1.33 | -161.38 | -210.74 | -14.1 | Upgrade |
Asset Writedown & Restructuring Costs | 60.01 | 59.94 | 1.16 | 33.59 | 2.19 | 74.72 | Upgrade |
Loss (Gain) From Sale of Investments | 0.35 | -12.44 | -4.48 | -20.33 | -0.85 | -35.38 | Upgrade |
Provision & Write-off of Bad Debts | 47.28 | 35.92 | 26.22 | -1.67 | 10.94 | 28.04 | Upgrade |
Other Operating Activities | 82.48 | 90.07 | 172.59 | 150.13 | 144.79 | 317.41 | Upgrade |
Change in Accounts Receivable | 81.71 | 118.67 | -94.42 | -237.95 | -613.94 | -569.32 | Upgrade |
Change in Inventory | 50.53 | 36.7 | -119.59 | 277.86 | -166.46 | 124.64 | Upgrade |
Change in Accounts Payable | -558.53 | -450.37 | 245.21 | -202.97 | -30.11 | 230.34 | Upgrade |
Change in Other Net Operating Assets | -0.38 | -0.38 | - | - | - | - | Upgrade |
Operating Cash Flow | 577.63 | 792.5 | 949.67 | 622.09 | -162.44 | -728.15 | Upgrade |
Operating Cash Flow Growth | 17.45% | -16.55% | 52.66% | - | - | - | Upgrade |
Capital Expenditures | -110.55 | -100.81 | -86.54 | -89.65 | -76.7 | -118.21 | Upgrade |
Sale of Property, Plant & Equipment | 5.68 | 1.2 | 35.94 | 151.03 | 177.46 | 15.19 | Upgrade |
Cash Acquisitions | -0.01 | -0.01 | - | - | - | 0.02 | Upgrade |
Divestitures | - | - | -156.64 | - | - | - | Upgrade |
Investment in Securities | 0.01 | - | - | - | - | 1.84 | Upgrade |
Other Investing Activities | 0.71 | 0.71 | 0.59 | 10.95 | -9.15 | - | Upgrade |
Investing Cash Flow | -104.16 | -98.91 | -206.64 | 72.34 | 91.62 | -101.17 | Upgrade |
Long-Term Debt Issued | - | 1,905 | 3,207 | 2,158 | 1,857 | 1,611 | Upgrade |
Long-Term Debt Repaid | - | -1,958 | -3,435 | -2,076 | -1,220 | -525.45 | Upgrade |
Net Debt Issued (Repaid) | -519.31 | -53.49 | -228.23 | 82.06 | 637.06 | 1,086 | Upgrade |
Issuance of Common Stock | - | - | 3.73 | 16.98 | 15.53 | - | Upgrade |
Repurchase of Common Stock | -3.98 | -3.98 | -8.36 | - | - | - | Upgrade |
Common Dividends Paid | -44.51 | -47.11 | -44.16 | -54.3 | -61.55 | -24.1 | Upgrade |
Other Financing Activities | -21.02 | -21.02 | 424.97 | 129.88 | -197.78 | - | Upgrade |
Financing Cash Flow | -588.82 | -125.61 | 147.94 | 174.62 | 393.26 | 1,061 | Upgrade |
Foreign Exchange Rate Adjustments | 0.6 | 2.24 | 0.92 | 3.74 | -2.91 | -0.87 | Upgrade |
Net Cash Flow | -114.75 | 570.22 | 891.89 | 872.79 | 319.54 | 231.22 | Upgrade |
Free Cash Flow | 467.08 | 691.69 | 863.14 | 532.45 | -239.13 | -846.37 | Upgrade |
Free Cash Flow Growth | 16.72% | -19.86% | 62.11% | - | - | - | Upgrade |
Free Cash Flow Margin | 2.89% | 4.28% | 5.58% | 3.86% | -1.87% | -7.85% | Upgrade |
Free Cash Flow Per Share | 0.18 | 0.28 | 0.35 | 0.21 | -0.10 | -0.34 | Upgrade |
Cash Income Tax Paid | 785.96 | 810.92 | 815.72 | 728.98 | 711.43 | 610.93 | Upgrade |
Levered Free Cash Flow | 586.13 | 636.83 | 898.47 | 837.21 | 310.96 | -416.28 | Upgrade |
Unlevered Free Cash Flow | 619.69 | 674.37 | 933.76 | 890.67 | 376.68 | -379.86 | Upgrade |
Change in Working Capital | -436.7 | -301.7 | 34.17 | -164.76 | -807.01 | -403.75 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.